Status:
COMPLETED
Breast Cancer Long-term Outcome of Cardiac Dysfunction
Lead Sponsor:
University Medical Center Groningen
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to assess the prevalence of cardiac dysfunction and (undiagnosed) heart failure in women registered in general practice with a history of breast cancer who received chemot...
Detailed Description
Background: Due to screening and progress in treatment the overall survival of women treated for breast cancer has increased over the last decades. Therefore, the long-term effects of breast cancer h...
Eligibility Criteria
Inclusion
- For breast cancer patients: minimum of 5 years after treatment for breast cancer with chemo- and/or radiotherapy and after 1970
- For breast cancer patients: younger than 80 at the time of diagnosis of breast cancer
- willing to sign an informed consent
- older than 18 at the time of inclusion
Exclusion
- Treatment with chemo- and/or radiotherapy for other types of cancer besides breast cancer
- women who are unable to participate (e.g. terminally or mentally ill)
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 24 2017
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT01904331
Start Date
June 1 2013
End Date
October 24 2017
Last Update
June 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen (UMCG)
Groningen, Netherlands, 9700RB